Wellington Management Group’s Capricor Therapeutics CAPR Stock Holding History

Wellington Management Group’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Sell	100,246 -8,358	-8%	-$253K	﹤0.01%	1588
2026 Q1	$3.3M	Sell	108,604 -19,666	-15%	-$524K	﹤0.01%	1469
2025 Q4	$3.7M	Sell	128,270 -4,045	-3%	-$52.8K	﹤0.01%	1472
2025 Q3	$954K	Buy	132,315 +438	+0.3%	+$3.23K	﹤0.01%	1787
2025 Q2	$1.31M	Buy	131,877 +21,146	+19%	+$223K	﹤0.01%	1674
2025 Q1	$1.05M	Buy	110,731 +69,772	+170%	+$968K	﹤0.01%	1697
2024 Q4	$565K	Buy	+40,959	New	+$718K	﹤0.01%	1815
2024 Q2	–	Sell	-79,759	Closed	-$542K	–	1891
2024 Q1	$542K	Buy	+79,759	New	+$386K	﹤0.01%	1800

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group's CAPR Position: Q2 2026 in Review

Wellington Management Group reduced its Capricor Therapeutics (CAPR) stake by 7.7% in Q2 2026, selling an estimated $253K and leaving 100,246 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Wellington Management Group first reported a position in CAPR in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.7M in Q4 2025. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Wellington Management Group held 100,246 shares of Capricor Therapeutics worth $2.41M as of Q2 2026.
Wellington Management Group sold 8,358 Capricor Therapeutics shares in Q2 2026, an estimated $253K.
Capricor Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1588 holding.
Wellington Management Group first reported a position in Capricor Therapeutics in Q1 2024 and has held it in 8 quarters since.
Wellington Management Group's Capricor Therapeutics position peaked at $3.7M in Q4 2025.
170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.